Interleukin 1 polymorphisms and intervertebral disc degeneration

Epidemiology

Volumn 15, Issue 5, 2004, Pages 626-633

  Solovieva, Svetlana ^a   Kouhia, Sanna ^b   Leino Arjas, Päivi ^a   Ala Kokko, Leena ^c,d   Luoma, Katariina ^a,e   Raininko, Raili ^f   Saarela, Janna ^b   Riihimäki, Hilkka ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e PEIJAS HOSPITAL   (Finland)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ARTICLE; CARPENTER; DNA POLYMORPHISM; DRIVER; EXTRACELLULAR MATRIX; GENE CLUSTER; GENE LOCUS; GENETIC RISK; GENOTYPE; HUMAN; INFLAMMATION; INTERVERTEBRAL DISK DEGENERATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS PULPOSUS; OFFICE WORKER; PRIORITY JOURNAL; WORKLOAD; COMPARATIVE STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; INTERVERTEBRAL DISK; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; OCCUPATION; PATHOLOGY; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; SPINE DISEASE;

ADULT; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-1; INTERVERTEBRAL DISK; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OCCUPATIONS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; SPINAL DISEASES;

EID: 13244279222     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000135179.04563.35     Document Type: Article

References (49)

1. Riihimäki H, Viikari-Juntura E. Back and limb disorders. In: McDonald C, Wheatley M, eds. Epidemiology of Work Related Diseases. London: BMJ Books; 2000:233-243.
2. Sambrook PN, MacGregor AJ, Spector TD. Genetic influences on cervical and lumbar disc degeneration. Arthritis Rheum. 1999;42:366-372.
3. Videman T, Gibbons LE, Battié MC, et al. The relative roles of intragenic polymorphisms of the vitamin D receptor gene in lumbar spine degeneration and bone density. Spine. 2001;26:E7-E12.
4. Annunen S, Paassilta P, Lohiniva J, et al. An allele of COL9A2 associated with intervertebral disc disease. Science. 1999;285:409-412.
5. Paassilta P, Lohiniva J, Annunen S, et al. Identification of a novel common genetic risk factors for lumbar disc disease. JAMA. 2001;285:1843-1849.
6. Kawaguchi Y, Osada R, Kanamori M, et al. Association between an aggrecan gene polymorphism and lumbar disc degeneration. Spine. 1999;24:2456-2460.
7. Takahashi M, Haro H, Wakabayashi Y, et al. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J Bone Joint Surg [Br]. 2001;83:491-495.
8. Rannou F, Corvol MT, Hudry C, et al. Sensitivity of anulus fibrosus cells to interleukin 1 beta. Comparison with articular chondrocytes. Spine. 2000;25:17-23.
9. Buckwalter JA. Aging and degeneration of the human intervertebral disc. Spine. 1995;20:1307-1314.
10. Adams MA, Freeman BJ, Morrison HP, et al. Mechanical initiation of intervertebral disc degeneration. Spine. 2000;25:1625-1636.
11. Handa T, Ishihara H, Ohshima H, et al. Effects of hydrostatic pressure on matrix synthesis and matrix metalloproteinase production in the human lumbar intervertebral disc. Spine. 1997;22:1085-1091.
12. Schneiderman G, Flannigan B, Kingston S, et al. Magnetic resonance imaging in the diagnosis of disc degeneration: correlation with discography. Spine. 1987;12:276-281.
13. Morgan S, Saifuddin A. MRI of the lumbar intervertebral disc. Clin Radiol. 1999;54:703-723.
14. Fardon DF, Milette PC. Nomenclature and classification of lumbar disc pathology. Spine. 2001;26:E93-E113.
15. Yamagishi M, Nemoto O, Kikuchi T, et al. Ruptured human disc tissue produce matrix metalloproteinase-3 and interleukin-1. Trans Orthop Res Soc. 1992;16:438
16. Takahashi H, Suguro T, Okazima Y, et al. Inflammatory cytokines in the herniated disc of the lumbar spine. Spine. 1996;21:218-224.
17. Shinmei M. Interleukin-1, tumour necrosis factor, and interleukin-6 as mediators of cartilage destruction. Semin Arthritis Rheum. 1989;18:27-32.
18. Maeda S, Kokubun S. Changes with age in proteoglycan synthesis in cells cultured in vitro from the inner and outer rabbit annulus fibrosus. Responses to interleukin 1 and interleukin-1 receptor antagonist protein. Spine. 2000;25:166-169.
19. Arend WP, Welgus HG, Thompson RC, et al. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest. 1990;85:1694-1697.
20. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002;13:323-340.
21. McDowell TL, Symons JA, Ploski R, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 1995;38:221-228.
22. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398-402.
23. di Giovine FS, Takhsh E, Blakemore AI, et al. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet. 1992;1:450
24. Pociot F, Molvig J, Wogensen L, et al. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest. 1992;22:396-402.
25. Clay FE, Cork MJ, Tarlow JK, et al. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet. 1994;94:407-410.
26. Dominici R, Cattaneo M, Malferrari G, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics. 2002;54:82-86.
27. Berger P, McConnell JP, Nunn M, et al. C-reactive protein levels are influenced by common IL-I gene variations. Cytokine. 2002;17:171-174.
28. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci. 2002;966:290-303.
29. Tsuzaki M, Guyton G, Garrett W, et al. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res. 2003;21:256-264.
30. Meier CA, Bobbioni E, Gabay C, et al. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab. 2002;87:1184-1188.
31. Mikuniya T, Nagai S, Tsutsumi T, et al. Proinflammatory or regulatory cytokines released from BALF macrophages of healthy smokers. Respiration. 1999;66:419-426.
32. Riihimäki H, Viikari-Juntura E, Moneta G, et al. Incidence of sciatic pain among men in machine operating, dynamic physical work, and sedentary work. Spine. 1994;19:138-142.
33. Orpana A, Pajukanta P, Palotie A, et al. SNP-TRAP, a simplified method for detecting SNPs. Am J Hum Genet. 2001;69(suppl 4):516
34. Pastinen T, Raitio M, Lindroos K, et al. A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res. 2000;10:1031-1042.
35. Luoma EK, Raininko R, Nummi PJ, et al. Suitability of cerebrospinal fluid as a signal-intensity reference on MRI: evaluation of signal-intensity variations in the lumbosacral dural sac. Neuroradiology. 1997;39:728-732.
36. Videman T, Battié MC, Gill K, et al. Magnetic resonance imaging findings and their relationships in the thoracic and lumbar spine. Insights into the etiopathogenesis of spinal degeneration. Spine. 1995;20:928-935.
37. Luoma K, Vehmas T, Riihimäki H, et al. Disc height and signal intensity of the nucleus pulposus on magnetic resonance imaging as indicators of lumbar disc degeneration. Spine. 2001;26:680-686.
38. Stabler A, Weiss M, Scheidler J, et al. Degenerative disk vascularization on MRI: correlation with clinical and histopathologic findings. Skeletal Radiol. 1996;25:119-126.
39. Schiebler ML, Grenier N, Fallon M, et al. Normal and degenerated intervertebral disk: in vivo and in vitro MR imaging with histopathologic correlation. AJR Am J Roentgenol. 1991;157:93-97.
40. Crock HV. Internal disc disruption. A challenge to disc prolapse fifty years on. Spine. 1986;11:650-653.
41. Luoma K, Riihimäki H, Luukkonen R, et al. Low back pain in relation to lumbar disc degeneration. Spine. 2000;25:487-492.
42. Yu SW, Haughton VM, Ho PS, et al. Progressive and regressive changes in the nucleus pulposus. Part II. The adult. Radiology. 1988;169:93-97.
43. Kang JD, Stefanovic-Racic M, McIntyre LA, et al. Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine. 1997;22:1065-1073.
44. Miyamoto H, Saura R, Harada T, et al. The role of cyclooxygenase-2 and inflammatory cytokines in pain induction of herniated lumbar intervertebral disc. Kobe J Med Sci. 2000;46:13-28.
45. Tountas NA, Casini-Raggi V, Yang H, et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology. 1999;117:806-813.
46. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 1998;47:195-198.
47. Nachman MW, Crowell SL. Estimate of the mutation rate per nucleotide in humans. Genetics. 2000;156:297-304.
48. Langdahl BL, Løkke E, Carstens M, et al. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res. 2000;15:402-414.
49. Battié MC, Videman T, Gibbons LE, et al. Determinants of lumbar disc degeneration. A study relating lifetime exposures and magnetic resonance imaging findings in identical twins. Spine. 1995;20:2601-2612.